Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 11, 2002, Pages 4957-4960

  Yamazaki, Yuji ^a,b,c,d,e   Okazaki, Ryo ^a,b,c,d,e   Shibata, Minako ^a,b,c,d,e   Hasegawa, Yukihiro ^a,b,c,d,e   Satoh, Kohei ^a,b,c,d,e   Tajima, Toshihiro ^a,b,c,d,e   Takeuchi, Yasuhiro ^a,b,c,d,e   Fujita, Toshiro ^a,b,c,d,e   Nakahara, Kazuhiko ^a,b,c,d,e   Yamashita, Takeyoshi ^a,b,c,d,e   Fukumoto, Seiji ^a,b,c,d,e,f  

^a KIRIN BREWERY CO LTD   (Japan)

^b TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c TOKYO METROPOLITAN CHILDREN'S MEDICAL CENTER   (Japan)

^d HOKKAIDO UNIVERSITY   (Japan)

^e UNIVERSITY OF TOKYO   (Japan)

^f UNIVERSITY OF TOKYO HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

24,25 DIHYDROXYVITAMIN D; ARGININE; CALCITRIOL; GENE PRODUCT; MONOCLONAL ANTIBODY; PHOSPHATE; PROTEIN FGF 23; SERINE; UNCLASSIFIED DRUG;

ADULT; AMINO TERMINAL SEQUENCE; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CARBOXY TERMINAL SEQUENCE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HORMONE BLOOD LEVEL; HUMAN; HYPOPHOSPHATEMIA; MALE; OSTEOMALACIA; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RICKETS; X CHROMOSOME LINKED DISORDER;

ADULT; ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; CALCITRIOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLAST GROWTH FACTORS; HUMANS; HYPOPHOSPHATEMIA, FAMILIAL; KINETICS; MALE; MIDDLE AGED; NEOPLASMS; OSTEOMALACIA;

EID: 18744371012     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2002-021105     Document Type: Article

References (10)

1. DiMeglio LA, White KE, Econs MJ 2000 Disorders of phosphate metabolism. Endocrinol Metab Clin North Am 29:591-609
2. The ADHR consortium 2000 Autosomal dominant hypophosphatemic rickets is associated with mutations in FGF23. Nat Genet 26:345-348
3. White KE, Jonnson KB, Carn G, Hampson G, Spector TD, Mannstadt M, Lorenz-Depiereux B, Miyauchi A, Yang IM, Ljunggren O, Meitinger T, Strom TM, Juppner H, Econs MJ 2001 The autosomal dominant hypophosphatemic rickets (ADHR) gene is a secreted polypeptide overexpressed by tumors that cause phosphate wasting. J Clin Endocrinol Metab 86:497-500
4. Shimada T, Mizutani S, Muto T, Yoneya T, Hino R, Takeda S, Takeuchi Y, Fujita T, Fukumoto S, Yamashita T 2001 Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci USA 98:6500-6505
5. Shimada T, Muto T, Urakawa I, Yoneya Y, Yamazaki Y, Okawa K, Takeuchi Y, Fujita T, Fukumoto S, Yamashihta T 2002 Mutant FGF-23 responsible for autosomal dominant hypophosphatemic ricktets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo. Endocrinology 143:3179-3182
6. The HYP consortium 1995 A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. Nat Genet 11:130-136
7. Harlow E, and Lane D 1988 Two antibody sandwich assays. In: Antibodies: A Laboratory Manual. New York: Cold Spring Harbor Laboratory; 579-581
8. Sato K, Tajima T, Nakase J, Adachi M, Asakura Y, Tachibana K, Suwa S, Katsumata N, Tanaka T, Hayashi Y, Abe S, Murashita M, Okuhara K, Shinohara N, Fujieda K 2000 Three novel PHEX gene mutations in Japanese patients with X-linked hypophosphatemic rickets. Pediatr Res 48:536-540
9. Drezner MK 2000 PHEX gene and hypophosphatemia. Kidney Int 50:9-18
10. Kumar R 2000 Tumor-induced osteomalacia and the regulation of phosphate homeostasis. Bone 27:333-338